Who are BREMEN eye drops's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Walgreen's Lubricant Balance, Lubricant Eye Drops (Optive™), Refresh Tears 0.5% Lubricant Eye Drops, B+L Advanced Eye Relief Lubricant Drop.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bremen-eye-drops.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

BREMEN eye drops — Competitive Intelligence Brief

BREMEN eye drops (BREMEN eye drops) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Artificial tear / Lubricant. Area: Ophthalmology.

phase 3 Artificial tear / Lubricant Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

BREMEN eye drops (BREMEN eye drops) — EMS. BREMEN eye drops is a topical ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
BREMEN eye drops TARGET	BREMEN eye drops	EMS	phase 3	Artificial tear / Lubricant
Walgreen's Lubricant Balance	Walgreen's Lubricant Balance	Scripps Poway Eyecare and Optometry	marketed	Artificial tear / Lubricant
Lubricant Eye Drops (Optive™)	Lubricant Eye Drops (Optive™)	Allergan	marketed	Artificial tear / Lubricant
Refresh Tears 0.5% Lubricant Eye Drops	Refresh Tears 0.5% Lubricant Eye Drops	Minnesota Eye Consultants, P.A.	marketed	Artificial tear / Lubricant eye drop
B+L Advanced Eye Relief Lubricant Drop	B+L Advanced Eye Relief Lubricant Drop	Massachusetts Eye and Ear Infirmary	marketed	Artificial tear / Lubricant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Artificial tear / Lubricant class)

Allergan · 1 drug in this class
EMS · 1 drug in this class
Massachusetts Eye and Ear Infirmary · 1 drug in this class
Scripps Poway Eyecare and Optometry · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). BREMEN eye drops — Competitive Intelligence Brief. https://druglandscape.com/ci/bremen-eye-drops. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab